Protalix BioTherapeutics
PLX
#8576
Rank
โ‚ฌ0.11 B
Marketcap
1,58ย โ‚ฌ
Share price
-1.78%
Change (1 day)
22.71%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -โ‚ฌ12.11 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚ฌ38.05 Million. In 2023 the company made an earning of โ‚ฌ11.22 Million, an increase over its 2022 earnings that were of -โ‚ฌ11.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ12.11 Million-207.84%
2023 โ‚ฌ11.22 M-199.05%
2022 -โ‚ฌ11.33 Million-40.38%
2021 -โ‚ฌ19.01 Million-732.31%
2020 โ‚ฌ3 M-130.53%
2019 -โ‚ฌ9.85 Million189.85%
2018 -โ‚ฌ3.4 Million-95.29%
2017 -โ‚ฌ72.12 Million308.12%
2016 -โ‚ฌ17.68 Million-32.37%
2015 -โ‚ฌ26.13 Million10.11%
2014 -โ‚ฌ23.73 Million-7.59%
2013 -โ‚ฌ25.68 Million
2011 -โ‚ฌ29.74 Million-19.39%
2010 -โ‚ฌ36.89 Million20.87%
2009 -โ‚ฌ30.52 Million32.26%
2008 -โ‚ฌ23.08 Million-5.46%
2007 -โ‚ฌ24.41 Million
2004 -โ‚ฌ0.16 Million12.35%
2003 -โ‚ฌ0.15 Million-11.1%
2002 -โ‚ฌ0.16 Million-57.03%
2001 -โ‚ฌ0.37 Million1.03%
2000 -โ‚ฌ0.37 Million-53.22%
1999 -โ‚ฌ0.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ95.31 Million 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.62 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.16 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.78 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel